UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs

Hepatology (Baltimore, Md.), 2017-04, Vol.65 (4), p.1117-1131

2017

Volltextzugriff (PDF)

Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure

Proceedings of the National Academy of Sciences - PNAS, 2011-05, Vol.108 (18), p.7505-7510

2011

Volltextzugriff (PDF)

Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core

PLoS pathogens, 2023-05, Vol.19 (5), p.e1010981-e1010981

2023

Volltextzugriff (PDF)

HIV-1-based Virus-like Particles that Morphologically Resemble Mature, Infectious HIV-1 Virions

Viruses, 2019-06, Vol.11 (6), p.507

2019

Volltextzugriff (PDF)

Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting

PloS one, 2019-08, Vol.14 (8), p.e0220986-e0220986

2019

Volltextzugriff (PDF)

Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response

PloS one, 2016-06, Vol.11 (6), p.e0157353-e0157353

2016

Volltextzugriff (PDF)

Memory B Cells, the HLA-B57 Allele and Natural Control of HIV Infection

EBioMedicine, 2017-07, Vol.21 (C), p.47-48

Center, Rob J.

2017

Volltextzugriff (PDF)

Hyperimmune Bovine Colostrum as a Low-Cost, Large-Scale Source of Antibodies with Broad Neutralizing Activity for HIV-1 Envelope with Potential Use in Microbicides

Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4310-4319

2012

Volltextzugriff (PDF)

Differentiating founder and chronic HIV envelope sequences

PloS one, 2017-02, Vol.12 (2), p.e0171572-e0171572

2017

Volltextzugriff (PDF)

Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env

Vaccines (Basel), 2021-03, Vol.9 (3), p.239

2021

Volltextzugriff (PDF)

Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine

The Journal of biological chemistry, 2020-05, Vol.295 (21), p.7179-7192

2020

Volltextzugriff (PDF)

NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients

Viral immunology, 2011-10, Vol.24 (5), p.359-368

2011

Volltextzugriff (PDF)

A pan‐genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice

Hepatology (Baltimore, Md.), 2022-10, Vol.76 (4), p.1190-1202

2022

Volltextzugriff (PDF)

Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs

Journal of virology, 2022-03, Vol.96 (5), p.e0167521-e0167521

2022

Volltextzugriff (PDF)

HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV

Journal of virology, 2017-09, Vol.91 (18)

2017

Volltextzugriff (PDF)

Crystal Structure of Human T Cell Leukemia Virus Type 1 gp21 Ectodomain Crystallized as a Maltose-Binding Protein Chimera Reveals Structural Evolution of Retroviral Transmembrane Proteins

Proceedings of the National Academy of Sciences - PNAS, 1999-04, Vol.96 (8), p.4319-4324

1999

Volltextzugriff (PDF)

Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine

PloS one, 2011-03, Vol.6 (3), p.e18225-e18225

2011

Volltextzugriff (PDF)

Oligomeric Structure of the Human Immunodeficiency Virus Type 1 Envelope Protein on the Virion Surface

Journal of Virology, 2002-08, Vol.76 (15), p.7863-7867

2002

Volltextzugriff (PDF)

Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission

Retrovirology, 2012-06, Vol.9 (1), p.54-54, Article 54

2012

Volltextzugriff (PDF)

Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection

Science translational medicine, 2017-08, Vol.9 (402)

2017

Volltextzugriff (PDF)

Rapid Degranulation of NK Cells following Activation by HIV-Specific Antibodies

The Journal of immunology (1950), 2009-01, Vol.182 (2), p.1202-1210

2009

Volltextzugriff (PDF)

Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design

AIDS (London), 2014-08, Vol.28 (13), p.1859-1870

2014

Volltextzugriff (PDF)

Role of education and differentiation in determining the potential of natural killer cells to respond to antibody-dependent stimulation

AIDS (London), 2014-11, Vol.28 (18), p.2781-2786

2014

Volltextzugriff (PDF)

Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin

The Journal of immunology (1950), 2014-09, Vol.193 (5), p.2554-2564

2014

Volltextzugriff (PDF)

Promoting Trimerization of Soluble Human Immunodeficiency Virus Type 1 (HIV-1) Env through the Use of HIV-1/Simian Immunodeficiency Virus Chimeras

Journal of Virology, 2004-03, Vol.78 (5), p.2265-2276

2004

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(96)
Bücher
(2)
Berichte
(1)

Sprache

Englisch
(99)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(63)
Humans
(51)
Animals
(23)
Immunology
(21)
Human Immunodeficiency Virus
(19)
Virology
(19)
Hiv
(18)
Female
(17)
Hiv Infections - Immunology
(16)
Proteins
(15)
Male
(14)
Vaccines
(14)
Biological And Medical Sciences
(13)
Env Gene Products, Human Immunodeficiency Virus - Immunology
(13)
Hiv-1 - Immunology
(13)
Amino Acid Sequence
(11)
Molecular Sequence Data
(11)
Multidisciplinary Sciences
(11)
Science & Technology - Other Topics
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs

Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure

Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core

HIV-1-based Virus-like Particles that Morphologically Resemble Mature, Infectious HIV-1 Virions

Conjugation of an scFab domain to the oligomeric HIV envelope protein for use in immune targeting

Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response

Memory B Cells, the HLA-B57 Allele and Natural Control of HIV Infection

Hyperimmune Bovine Colostrum as a Low-Cost, Large-Scale Source of Antibodies with Broad Neutralizing Activity for HIV-1 Envelope with Potential Use in Microbicides

Differentiating founder and chronic HIV envelope sequences

Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env

Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine

NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients

A pan‐genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice

Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs

HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV

Crystal Structure of Human T Cell Leukemia Virus Type 1 gp21 Ectodomain Crystallized as a Maltose-Binding Protein Chimera Reveals Structural Evolution of Retroviral Transmembrane Proteins

Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine

Oligomeric Structure of the Human Immunodeficiency Virus Type 1 Envelope Protein on the Virion Surface

Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission

Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection

Rapid Degranulation of NK Cells following Activation by HIV-Specific Antibodies

Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design

Role of education and differentiation in determining the potential of natural killer cells to respond to antibody-dependent stimulation

Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin

Promoting Trimerization of Soluble Human Immunodeficiency Virus Type 1 (HIV-1) Env through the Use of HIV-1/Simian Immunodeficiency Virus Chimeras

Suchergebnisse filtern